Rajjit Abrol, MD
Clinical Cardiac Electrophysiology · Plano, TXNPI 1164530739
Payments from drug & device makers
Across 327 payments — averaging $61.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$12K
- Abbott$2K
- Biosense Webster, Inc.$1K
- Boston Scientific$813
- Johnson & Johnson$711
- Impulse Dynamics (USA) Inc.$385
- plus $2K from 32 others
What the payments were for
- Speaking & faculty fees$4,37522%
- Travel & lodging$2,62413%
- Food & beverage$12,97065%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 107 | $12,360 |
| Abbott | 30 | $2,244 |
| Biosense Webster, Inc. | 17 | $1,038 |
| Boston Scientific | 16 | $813 |
| Johnson & Johnson | 43 | $711 |
| Impulse Dynamics (USA) Inc. | 3 | $385 |
| E.r. Squibb & Sons, L.L.C. | 15 | $297 |
| Novartis | 10 | $197 |
| Merck | 9 | $182 |
| Heartflow, Inc. | 3 | $175 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 7 | $161 |
| Amarin Pharma, Inc. | 8 | $148 |
| Amgen | 8 | $148 |
| Pfizer | 7 | $125 |
| Tactile Systems Technology Inc | 5 | $110 |
| ZOLL Respicardia, Inc. | 1 | $105 |
| Boehringer Ingelheim | 4 | $82 |
| Sanofi-aventis U.S. LLC | 5 | $76 |
| Inspire Medical Systems, Inc. | 3 | $62 |
| Recor Medical Inc | 3 | $55 |
| Potrero Medical, Inc. | 1 | $50 |
| Innovation Technologies Inc | 1 | $47 |
| Angiodynamics, Inc. | 1 | $45 |
| Esperion Therapeutics, Inc. | 2 | $39 |
| Astellas Pharma US Inc | 2 | $38 |
| Regeneron Healthcare Solutions, Inc. | 2 | $36 |
| Kestra Medical Technology Services, Inc. | 1 | $29 |
| Altathera Pharmaceuticals LLC | 2 | $26 |
| Cardiva Medical, Inc. | 1 | $25 |
| Bardy Diagnostics, Inc. | 2 | $24 |
| Cvrx, Inc. | 1 | $22 |
| Convatec Inc. | 1 | $20 |
| Novo Nordisk | 1 | $19 |
| AstraZeneca | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Baxter Healthcare | 1 | $15 |
| Portola Pharmaceuticals, LLC | 1 | $15 |
| Medicomp Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Micra$1,753
- Arctic Front$1,118
- OPTIMIZER$661
- Confirm Rx$420
- AVEIR$415
- Carto 3$360
- GENERAL - THERAPIES$241
- AURORA EV-ICD MRI SURESCAN$176
- COBALT DR MRI SURESCAN$173
- SelectSecure$170
- ENSITE$160
- AMPERE$155
- JOT DX$147
- Compia MRI$147
- GALLANT$145
- ASSURITY$115
- Assurity Pacemaker$114
- WATCHMAN Access System$110
- Evera$108
- remede System$105
How this compares
$19,969 in reported general payments places this provider in the 30th percentile of 233 clinical cardiac electrophysiology providers in Texas.
See all clinical cardiac electrophysiology providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 221 | $230,319 |
| XareltoRivaroxaban | 162 | $164,144 |
| Dofetilide | 126 | $25,736 |
| SotalolSotalol Hcl | 319 | $5,981 |
| Metoprolol Succinate | 259 | $3,770 |
| Flecainide Acetate | 102 | $3,203 |
| Acebutolol Hcl | 30 | $1,808 |
| Amiodarone Hcl | 158 | $1,606 |
| Pindolol | 15 | $1,151 |
| Furosemide | 103 | $583 |
| Torsemide | 35 | $525 |
| Warfarin Sodium | 39 | $518 |
| ClopidogrelClopidogrel Bisulfate | 51 | $509 |
| Cephalexin | 79 | $483 |
| Midodrine Hcl | 16 | $441 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $125 | $230,319221 claims |
| Johnson & JohnsonXarelto | $711 | $164,144162 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 30th percentile of 233 clinical cardiac electrophysiology providers in Texas.
Other clinical cardiac electrophysiology in Plano
- James DevillePlano$1.5M
- Hafiza KhanPlano$373K
- Andrea NataleAustin$7.8M
- George ManoukianShenandoah$3.2M
- Rodney HortonAustin$2.5M
- Stanislav WeinerLongview$2.4M
- Michael DelaughterBedford$2.1M
- Robert CanbyAustin$1.5M
- Amin Al-AhmadAustin$1.4M
- Theodore TakataFort Worth$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.